New lupus drug candidate cenerimod tested in chinese patients
Disease control
ENROLLING_BY_INVITATION
This study is testing an experimental drug called cenerimod in 15 Chinese adults (ages 18-75) with moderate-to-severe systemic lupus erythematosus (SLE) who are already on standard treatments. The goal is to check the drug's safety, how the body handles it, and its effect on immu…
Phase: PHASE2 • Sponsor: Viatris Pharmaceuticals Co., Ltd. • Aim: Disease control
Last updated May 15, 2026 11:57 UTC